Welcome to Chinese Journal of Biological Control,Today is

Chinese Journal of Biological Control ›› 2020, Vol. 36 ›› Issue (6): 837-841.DOI: 10.16409/j.cnki.2095-039x.2020.06.013


Commercialization Status and Prospect Analysis of Bacillus thuringiensis G033A Product

WANG Yuhang1, SHU Changlong1, GENG Lili1, LIU Huamei2, ZAHNG Jie1   

  1. 1. State Key Laboratory for Biology of Plant Diseases and Insect Pests/Institute of Plant Protection, Chinese Academy of Agricultural Sciences, Beijing 100193, China;
    2. Wuhan Keno Biotechnology Co., Ltd, Wuhan 430074, China
  • Received:2019-08-17 Published:2021-01-09

Abstract: Bacillus thuringiensis (Bt) strain G033A is the first genetically engineered bacterium to be approved to commercialize in China, and the first Bt product for coleopteran pest control. It is also highly toxic to lepidopteran pests. This article summarizes the research and development background of G033A product, construction process, biosafety assessment, product registration, application technique and extension, and evaluates the application prospects of G033A in order to provide guidance for the large-scale application of G033A. At present, the resistance of insect pests to chemical insecticides is becoming more and more serious, and people's demand for high-quality, green and safe agricultural products is becoming more and more urgent, so it can be expected that G033A product will play significant role for biocontrol of both lepidopteran and coleopteran pests, and the application prospects is extensive.

Key words: Bacillus thuringiensis G033A product, coleopteran pests, commercialization, prospect

CLC Number: